These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25258650)

  • 1. The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapy.
    Zhang P; Xi M; Li QQ; He LR; Liu SL; Zhao L; Shen JX; Liu MZ
    J Cancer; 2014; 5(8):689-95. PubMed ID: 25258650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy.
    Xiao Y; Ren YK; Cheng HJ; Wang L; Luo SX
    Int J Clin Exp Pathol; 2015; 8(5):5273-81. PubMed ID: 26191228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity modified Glasgow prognostic score (HS-mGPS) Is superior to the mGPS in esophageal cancer patients treated with chemoradiotherapy.
    Chen P; Fang M; Wan Q; Zhang X; Song T; Wu S
    Oncotarget; 2017 Nov; 8(59):99861-99870. PubMed ID: 29245945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
    Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
    Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of Systemic Inflammation on Treatment Response and Survival in Anal Squamous Cell Cancer.
    Knight K; Choong JX; McKee RF; Anderson JH; Horgan PG; McMillan DC; McDonald A; Roxburgh CS
    Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):e22-e30. PubMed ID: 32709540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified Glasgow prognostic score predicts the prognosis of patients with advanced esophageal squamous cell carcinoma: A propensity score-matched analysis.
    Cui C; Wu X; Deng L; Wang W; Cui W; Wang Y
    Thorac Cancer; 2022 Jul; 13(14):2041-2049. PubMed ID: 35624549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer.
    Minami S; Ogata Y; Ihara S; Yamamoto S; Komuta K
    Lung Cancer (Auckl); 2017; 8():249-257. PubMed ID: 29263709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
    Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
    BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer.
    Otowa Y; Nakamura T; Takiguchi G; Tomono A; Yamamoto M; Kanaji S; Imanishi T; Suzuki S; Tanaka K; Itoh T; Kakeji Y
    Dis Esophagus; 2016; 29(2):146-51. PubMed ID: 25515972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation-based prognostic scores predict the prognosis of locally advanced cervical esophageal squamous cell carcinoma patients receiving curative concurrent chemoradiotherapy: a propensity score-matched analysis.
    Wu CC; Li SH; Lu HI; Lo CM; Wang YM; Chou SY; Chen YH
    PeerJ; 2018; 6():e5655. PubMed ID: 30258731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
    Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer.
    Zhu L; Li X; Shen Y; Cao Y; Fang X; Chen J; Yuan Y
    Onco Targets Ther; 2016; 9():4879-86. PubMed ID: 27540301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the modified Glasgow Prognostic Score (mGPS) have a prognostic role in esophageal cancer?
    Walsh SM; Casey S; Kennedy R; Ravi N; Reynolds JV
    J Surg Oncol; 2016 Jun; 113(7):732-7. PubMed ID: 27004839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of modified Glasgow prognostic score in patients with esophageal squamous cell cancer: a Meta-analysis.
    Wang Y; Chen L; Wu Y; Li P; Che G
    Nutr Cancer; 2020; 72(7):1146-1154. PubMed ID: 31617767
    [No Abstract]   [Full Text] [Related]  

  • 15. Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
    Brown JT; Liu Y; Shabto JM; Martini DJ; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni LB; Joshi SS; Kissick H; Ogan K; Harris WB; Carthon BC; Kucuk O; Master VA; Bilen MA
    Oncologist; 2021 May; 26(5):397-405. PubMed ID: 33634507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the treatment outcome of nivolumab in recurrent or metastatic head and neck squamous cell carcinoma: prognostic value of combined performance status and modified Glasgow prognostic score.
    Ueki Y; Takahashi T; Ota H; Shodo R; Yamazaki K; Horii A
    Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2341-2347. PubMed ID: 32239313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of modified Glasgow Prognostic Score in patients with non-metastatic clear cell renal cell carcinoma.
    Cho DS; Kim SI; Choo SH; Jang SH; Ahn HS; Kim SJ
    Scand J Urol; 2016 Jun; 50(3):186-91. PubMed ID: 26878156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib Treatment.
    Ishihara H; Kondo T; Omae K; Takagi T; Iizuka J; Kobayashi H; Tanabe K
    Target Oncol; 2016 Oct; 11(5):605-617. PubMed ID: 27023922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment.
    Alan O; Telli TA; Basoğlu T; Arikan R; Demircan NC; Ercelep O; Bozkurt S; Atasoy BM; Dane F; Yumuk PF
    Clin Neurol Neurosurg; 2020 Sep; 196():105976. PubMed ID: 32531614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
    Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
    Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.